1 / 15

Brain Mass

Brain Mass. Student Name: Jack Li Period: 3 Date: 7/22/09. History. CC: “weakness”

Télécharger la présentation

Brain Mass

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Brain Mass Student Name: Jack Li Period: 3 Date: 7/22/09

  2. History • CC: “weakness” • HPI: 69 yo ♂ c/o worsening L upper and lower extremity weakness x 2 mos, frequent falls to the left, persistent “travelling” black dot in L eye, Ø vertigo, nausea, vomiting, weight loss, F/C, but + night sweats x 2-3 yrs • PMH: arthritis, ?steel fragment in L eye, self-limited hematuria x1yr • FHx: +DM, emphysema, father died ~age 60 for unknown cause, no hx of cancers noted • SHx: prior smoker 25+ pack-yrs, hx EtOH, no IVDU, +asbestos/lead exposure, lives at home w/ wife • Meds: aleve, vitamin E, garlic pills • Allergies: NKDA • ROS: + urinary hesitancy, dribbling, chronic cough

  3. Physical Exam and Labs • Physical exam: • Vitals: T 97.6 HR 67 RR 10 BP 154/92 97% RA • Neuro: • CN 2-12: L facial droop, o/w grossly intact • Strength: 4/5 on L • Sensation: intact bilaterally • DTR: hyper-reflexia on L, 1+ R, beat L ankle clonus, Babinski indeterminate • Cerebellar: sluggish on L • No other significant findings • Labs: • WBC: 6.7 • Hgb: 14.3 • Plts: 201 • Na 140, K 3.6, Cl 107, bicarb 26, BUN 13, Cr 1.0, Gluc 106 • protein 6.6, albumin 4.0 • AST/ALT/alk. phos: 18/16/68 • INR 1.1

  4. Findings • MRI Brain • Loss of normal gray white matter differentiation on R temporal lobe insula with hypoattenuation suggesting necrosis • Mass measured to be 8.7 x 4.7 x 5.2 cm • Small focal high signal intensities in operculum and lateral margins of basal ganglia suggesting microhemorrhages or calcifications • Moderate mass effect with vasogenic edema and shift to the left by 1.3 cm with mild transfalcial herniation • Well-defined neovascularity around periphery of tumor, suggesting aggressive behavior of disease process

  5. T1

  6. T2

  7. T2 FLAIR

  8. T1 Coronal

  9. T1 Sagittal

  10. Differential Diagnosis • Glioblastoma multiforme • Astrocytoma • Primary CNS Lymphoma

  11. Diagnosis Glioblastoma multiforme

  12. Glioblastoma Multiforme Epidemiology: Accounts for 70% of all brain tumors Higher incidence in more developed nations Pathophysiology: Arise from neural progenitor cells/multipotent stem cells Clinical sxs: General: headaches, seizures, nausea/vomiting, syncope, cognitive dysfunction Focal: weakness, sensory loss, aphasia, visual-spatial dysfunction Diagnosis: MRI (functional, perfusion) Magnetic resonance spectroscopy (MRS) CT/PET/SPECT

  13. MRI • Gadolinium-enhanced MRI usually only test needed to evaluate brain tumor • Advantages: • Superior evaluation of surrounding soft tissue (meninges, subarachnoid space, posterior fossa) • Can define vasculature distribution around abnormality • No radiation • Disadvantages: • Expensive ($3000-$4000) • Difficult exam (motion artifacts, claustrophobia) • Pacemakers are contraindicated

  14. Post-Tumor Debulking T1

  15. References • Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009;472:323-42. • Pathogenesis and biology of malignant gliomas. UptoDate 2009. • Gutin, PH, Posner, JB. Neuro-oncology: diagnosis and management of cerebral gliomas--past, present, and future. Neurosurgery 2000; 47:1. • Radiographic images obtained from VA CPRS/Stentor • Cost information from Complete Guide to Medical Tests by H. Winter Griffin, MD

More Related